ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial

08 نوفمبر 2022 08:00:03 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022

31 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

27 سبتمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Fall Investor Conferences

07 سبتمبر 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update

11 أغسطس 2022 16:05:01 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022

28 يوليو 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

01 يوليو 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation

29 يونيو 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference

21 يونيو 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users

01 يونيو 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at LD Micro Invitational Conference

26 مايو 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference

13 مايو 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update

12 مايو 2022 16:00:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

27 أبريل 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022

21 أبريل 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

15 مارس 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award

11 مارس 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update

10 مارس 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation in March Investor Conferences

08 مارس 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022

24 فبراير 2022 08:00:03 بحسب Nasdaq GlobeNewswire